Inter Pharma Balance Sheet Health
Financial Health criteria checks 5/6
Inter Pharma has a total shareholder equity of THB2.1B and total debt of THB247.9M, which brings its debt-to-equity ratio to 11.7%. Its total assets and total liabilities are THB2.9B and THB763.8M respectively. Inter Pharma's EBIT is THB58.0M making its interest coverage ratio 2.6. It has cash and short-term investments of THB310.9M.
Key information
11.7%
Debt to equity ratio
฿247.90m
Debt
| Interest coverage ratio | 2.6x |
| Cash | ฿310.92m |
| Equity | ฿2.12b |
| Total liabilities | ฿763.83m |
| Total assets | ฿2.88b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: IP-R's short term assets (THB1.1B) exceed its short term liabilities (THB429.7M).
Long Term Liabilities: IP-R's short term assets (THB1.1B) exceed its long term liabilities (THB334.1M).
Debt to Equity History and Analysis
Debt Level: IP-R has more cash than its total debt.
Reducing Debt: IP-R's debt to equity ratio has reduced from 14.4% to 11.7% over the past 5 years.
Debt Coverage: IP-R's debt is well covered by operating cash flow (61.8%).
Interest Coverage: IP-R's interest payments on its debt are not well covered by EBIT (2.6x coverage).